Monograph
N05AB03 - Perphenazine |
Propably not porphyrinogenic |
PNP |
Rationale
Extensively metabolised. Substrate of CYP 2D6 and 3A4(major enzymes), 1A2, 2C18, 2C19, 2C9. Inhibitor of CYPs 1A2 and 2D6. No indications of CYP-inducing effects. References state non-porphyrinogenicity.
Chemical description
Low-dose phenothiazine neuroleptic with strong antiemetic effect. Extensively metabolized mainly by CYP 2D6. No data pointing to CYP-induction. MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use (phenothiazines). South African list: use with care Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Decentan 
Fentazin · Perphenazine 
Trilafon 
Peratsin · Perphenazin · Trilafon 
Peratsin · Trilafon 
Peratsin
© NAPOS 2025